FR2823672B1 - Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes - Google Patents

Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes

Info

Publication number
FR2823672B1
FR2823672B1 FR0105463A FR0105463A FR2823672B1 FR 2823672 B1 FR2823672 B1 FR 2823672B1 FR 0105463 A FR0105463 A FR 0105463A FR 0105463 A FR0105463 A FR 0105463A FR 2823672 B1 FR2823672 B1 FR 2823672B1
Authority
FR
France
Prior art keywords
preparation
medicinal product
hop extracts
estrogenic properties
estrogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0105463A
Other languages
English (en)
Other versions
FR2823672A1 (fr
Inventor
Sevenier Cedric Bourges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berkem SA
Original Assignee
Berkem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berkem SA filed Critical Berkem SA
Priority to FR0105463A priority Critical patent/FR2823672B1/fr
Priority to US10/475,662 priority patent/US20050019438A1/en
Priority to CA002445087A priority patent/CA2445087A1/fr
Priority to PCT/FR2002/001295 priority patent/WO2002085393A1/fr
Priority to EP02732826A priority patent/EP1381379A1/fr
Publication of FR2823672A1 publication Critical patent/FR2823672A1/fr
Application granted granted Critical
Publication of FR2823672B1 publication Critical patent/FR2823672B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
FR0105463A 2001-04-23 2001-04-23 Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes Expired - Fee Related FR2823672B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0105463A FR2823672B1 (fr) 2001-04-23 2001-04-23 Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
US10/475,662 US20050019438A1 (en) 2001-04-23 2002-04-15 Hop extracts and use thereof in the production of a medicament having estrogenic properties
CA002445087A CA2445087A1 (fr) 2001-04-23 2002-04-15 Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
PCT/FR2002/001295 WO2002085393A1 (fr) 2001-04-23 2002-04-15 Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
EP02732826A EP1381379A1 (fr) 2001-04-23 2002-04-15 Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0105463A FR2823672B1 (fr) 2001-04-23 2001-04-23 Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes

Publications (2)

Publication Number Publication Date
FR2823672A1 FR2823672A1 (fr) 2002-10-25
FR2823672B1 true FR2823672B1 (fr) 2004-03-12

Family

ID=8862603

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0105463A Expired - Fee Related FR2823672B1 (fr) 2001-04-23 2001-04-23 Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes

Country Status (5)

Country Link
US (1) US20050019438A1 (fr)
EP (1) EP1381379A1 (fr)
CA (1) CA2445087A1 (fr)
FR (1) FR2823672B1 (fr)
WO (1) WO2002085393A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004016486D1 (de) * 2003-04-08 2008-10-23 Kirin Brewery Zusammensetzung zur hemmung oder prävention der verringerung der knochendichte
EP1543834A1 (fr) * 2003-12-16 2005-06-22 Biodynamics Production de d'extraits de houblon ayant une bioactivité oestrogénique et anti-proliférative
DE102004063125B4 (de) 2004-12-22 2007-03-15 Ta-Xan-Ag Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke
MX2007011142A (es) * 2005-03-12 2007-11-06 Unilever Nv Composiciones para el cuidado del cabello y/o cuero cabelludo que incorporan compuestos de amino-oxo-indol-ilideno.
ATE483460T1 (de) * 2005-03-12 2010-10-15 Unilever Nv Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
EP1981471A1 (fr) * 2005-03-12 2008-10-22 Unilever Plc Compositions pour le soins des cheveux et/ou du ccuir chevelu comprenant des terpenoides
ITMI20060122A1 (it) * 2006-01-25 2007-07-26 Polichem Sa Composizioni per uso vaginale
WO2008089137A1 (fr) * 2007-01-12 2008-07-24 Bioactives, Inc. Méthodes d'extraction du houblon et mélanges à base de houblon
US8142821B2 (en) * 2007-08-15 2012-03-27 Flazan GmbH & Co. KG Xanthohumol-enriched hop extract
AU2008286868B2 (en) * 2007-08-15 2013-03-28 Flaxan Gmbh & Co. Kg Xanthohumol-enriched hop extract
KR100873714B1 (ko) 2008-02-01 2008-12-12 전북대학교산학협력단 잔토휴몰을 유효 성분으로 함유하여 멜라닌 색소 생성을억제하는 미백 조성물
FR2940123B1 (fr) * 2008-12-22 2011-04-22 Granions Lab Des Association de composes pour le traitement ou la prevention des bouffees de chaleur et des sueurs engendrees par la menopause
CA2745020C (fr) * 2008-12-26 2013-10-15 Natural Endotech Co., Ltd. Composition de phyto-ƒstrogenes dans le traitement prophylactique ou therapeutique de symptomes associes a la menopause
KR101067028B1 (ko) 2010-02-12 2011-09-23 한국과학기술연구원 산나물 추출물을 함유하는 여성 폐경기 증후군 예방 및 치료용 조성물
EP2392325A1 (fr) 2010-06-04 2011-12-07 Universitätsklinikum Münster Nouveaux composés pour la prévention et/ou le traitement de l'arthrose
CN102040500B (zh) * 2010-11-29 2013-04-03 天津科技大学 一种黄腐酚和黄酮类化合物的萃取分离方法
ES2423254B1 (es) 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis
EP2735302A1 (fr) * 2012-11-22 2014-05-28 KAIROSmetics UG Composition topique comprenant un extrait de houblon et naringénine de 8-prenyl et ses utilisations
CN104116022B (zh) * 2013-04-26 2016-08-10 中国科学院理化技术研究所 用于改善妇女更年期综合症的复合保健食品及其制备方法
US20210401918A1 (en) * 2018-11-23 2021-12-30 Naturetech Co. Ltd. Composition comprising combination of red clover extract and hops extract for improvement of menopausal disorder
US10765966B2 (en) * 2019-02-06 2020-09-08 Heinkel Filtering Systems. Inc. Biomass extraction and centrifugation systems and methods
US10751640B1 (en) 2019-10-30 2020-08-25 Heinkel Filtering Systems, Inc. Cannabidiol isolate production systems and methods
US10858303B1 (en) 2019-10-30 2020-12-08 Heinkel Filtering Systems, Inc. Cannabidiol isolate production systems and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07285856A (ja) * 1994-04-21 1995-10-31 Hoechst Japan Ltd 骨粗鬆症治療剤
DE19939350B4 (de) * 1999-08-19 2005-04-07 Plantextrakt Gmbh & Co. Kg Hopfenextrakt und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
FR2823672A1 (fr) 2002-10-25
CA2445087A1 (fr) 2002-10-31
US20050019438A1 (en) 2005-01-27
WO2002085393A1 (fr) 2002-10-31
EP1381379A1 (fr) 2004-01-21

Similar Documents

Publication Publication Date Title
FR2823672B1 (fr) Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
DE60235719D1 (de) Frauenhygieneartikel zur verabreichung von arzneimittel
AU2001286940A1 (en) Drug delivering prostheses and methods of use
AR028426A1 (es) Una composicion farmaceutica y procedimiento de tratamiento de enfermedades de disfunsion cognitiva en un mamifero
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU6158001A (en) Drug/drug delivery systems for the prevention and treatment of vascular disease
DE60100866D1 (de) Cyklosporin, Hyaluronsäure und Polysorbate enthaltenes Augenarzneimittel
HUP0101137A3 (en) Anticoagulant amidines and their pharmaceutical use
EP1364957A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
EP1364958A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
HUP0400529A3 (en) Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
EP1257255A4 (fr) Produit therapeutique, son application et sa formulation
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
IL149209A0 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
FR2803753B1 (fr) Preparations cosmetiques et/ou pharmaceutiques comportant un extrait d'arrabidaea chica
EP1308509A4 (fr) Peptide acitf sur le plan physiologique et utilisation de celui-ci
AU4319001A (en) Microcompetiton and human disease
HK1047037B (zh) 含聚殼糖的蘭諾索爾(毫微溶膠)藥物製劑及其製備
IL160886A0 (en) Nicotine containing pharmaceutical formulations and use thereof

Legal Events

Date Code Title Description
GC Lien (pledge) constituted
TP Transmission of property
ST Notification of lapse

Effective date: 20101230